119th Congress Health
H.R. 1843: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Introduced
- Introduced (completed)
- Passed House (not reached)
- Passed Senate (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill requires the Food and Drug Administration (FDA) to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why). The FDA must also update or publish guidance on how it makes such determinations.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Kevin Mullin D-CAOriginal
Who scored on this bill
- 1Neal Dunn SponsorDrew cross-party cosponsors, introduced2 events+6
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Neal Dunn
History
- Introduced in the House by Neal Dunn.
Show the full action history (2 actions)
- Introduced in House
- Referred to the House Committee on Energy and Commerce.